Clinical trial
Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT
NCT06177561 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT
- Lead sponsor
- Ruijin Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 9, 2023
- Completion date
- November 8, 2025
- Enrollment
- 38 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.